Versa Capital Fund III and Associates Fully Exit Position in Picard Medical, Inc.

This Schedule 13G/A filing, dated June 5, 2026, represents a full exit of holdings in Picard Medical, Inc. (PMI) by a group of reporting persons led by Versa Capital Fund III, L.P. and Gregory L. Segall. The reporting group, which also includes Sindex SSI Lending, LLC, Versa FGP-III, L.P., Versa UGP-III, LLC, and Versa Capital Group, LLC, reported a beneficial ownership of 0 shares, representing 0.0% of the company's common stock. This amendment follows a previous filing and indicates that the reporting persons have ceased to be beneficial owners of more than five percent of the class of securities. The event triggering this filing occurred on June 3, 2025. The filing was signed by Randall Schultz as Attorney-in-Fact for all involved entities. The reporting persons are based in Philadelphia, PA, and the issuer, Picard Medical, Inc., is headquartered in Tucson, AZ.